## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence as presented in the abstract; no access to full text, figures, tables, or methods
- **Shared manuscript claim summary** The authors use all-atom classical molecular dynamics simulations to show that adenosine triphosphate (ATP) at millimolar concentrations inhibits oligomerization of hIAPP(22-28) and full-length hIAPP, and destabilizes preformed hIAPP protofibrils, via interactions dominated by hydrophobic contacts with the adenosine moiety and supported by hydrogen bonding, hydrophobic, pi-pi, and N-H-pi stacking interactions.
- **Visible evidence base** Abstract text only; no simulation details, system setup, force field parameters, convergence criteria, or quantitative results are provided
- **Missing materials affecting confidence** Full methods, simulation parameters, force field validation, system size and composition, simulation timescales, replica or repeat runs, free energy calculations, structural analyses, and all figures and tables

## Reviewer
- **Overall assessment** The abstract presents a plausible and potentially interesting computational study on ATP as an inhibitor of hIAPP aggregation. The topic is timely given the emerging role of ATP as a biological hydrotrope and aggregation modulator. However, the abstract alone provides insufficient detail to evaluate the technical rigor of the simulations, the statistical significance of the observations, or the robustness of the conclusions. The claims are qualitatively stated without quantitative support, and several assertions go beyond what can be inferred from the provided material.
- **Who would be interested in the results, and why** Researchers in the fields of protein misfolding and aggregation, type II diabetes mellitus pathophysiology, amyloid inhibitor design, and molecular dynamics simulation of intrinsically disordered proteins. The work may also appeal to those studying ATP as a multifunctional cellular molecule beyond its canonical energy currency role.
- **Major strengths** The study addresses a clinically relevant problem, namely hIAPP aggregation in T2DM, and explores a novel therapeutic angle using ATP. The use of both a fragment (hIAPP(22-28)) and the full-length peptide is a reasonable strategy to probe sequence-dependent effects. The identification of specific interaction types (hydrogen bonding, hydrophobic, pi-pi, N-H-pi) provides a mechanistic framework that could inform future inhibitor design.
- **Major Concerns**  
  - **Concern ID** R1-M1  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Technical soundness  
  - **Claim pointer** The authors claim that ATP inhibits hIAPP oligomerization and disassembles preformed protofibrils based on all-atom classical molecular dynamics simulations.  
  - **Evidence pointer** Abstract; location not provided  
  - **Concern** The abstract provides no information on simulation timescales, system size, force field parameters, water model, ion concentration, temperature, pressure coupling, or number of independent replicates. Without these details, it is impossible to assess whether the observed behaviors are converged, statistically robust, or artifacts of the simulation setup.  
  - **Why it matters** Molecular dynamics simulations of intrinsically disordered proteins and aggregation processes are highly sensitive to force field choice and sampling length. Claims of inhibition and disassembly require demonstration of equilibrium sampling and reproducibility across multiple independent trajectories.  
  - **Resolution test** Provide full methods including force field validation, simulation length, number of replicates, and convergence metrics. Show that the observed monomeric state and protofibril destabilization are stable over extended timescales and reproducible across independent runs.

  - **Concern ID** R1-M2  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Evidence sufficiency  
  - **Claim pointer** The authors claim that ATP preferentially interacts with hydrophobic residues of hIAPP(22-28) and terminal and turn residues of full-length hIAPP, and that the adenosine moiety is more in contact with peptide residues than the triphosphate moiety.  
  - **Evidence pointer** Abstract; location not provided  
  - **Concern** No quantitative data are provided to support these interaction preferences. Contact frequencies, residence times, interaction energies, or radial distribution functions are not reported. The claim of preferential interaction is qualitative and cannot be evaluated.  
  - **Why it matters** The mechanistic conclusion rests on the identification of specific interaction partners and moieties. Without quantitative interaction analysis, the proposed mechanism is speculative.  
  - **Resolution test** Provide quantitative interaction analyses such as per-residue contact maps, interaction energy decomposition, and time-averaged contact probabilities for both the adenosine and triphosphate moieties.

  - **Concern ID** R1-M3  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Claim scope  
  - **Claim pointer** The authors state that ATP inhibits hIAPP aggregation and disassembles preformed protofibrils, and that this insight can be beneficial for the design of novel amyloid inhibitors.  
  - **Evidence pointer** Abstract; location not provided  
  - **Concern** The abstract does not specify the concentration of ATP used in the simulations, nor does it compare the observed effects with any control conditions (e.g., no ATP, other small molecules). The claim of inhibition and disassembly is made without reference to a dose-response or comparative baseline.  
  - **Why it matters** The biological relevance of ATP as an inhibitor depends on its effective concentration range. Without concentration-dependent data and appropriate controls, the specificity of the observed effect cannot be established.  
  - **Resolution test** Report ATP concentrations used, include control simulations without ATP, and if possible, test a range of ATP concentrations to demonstrate a dose-dependent effect.

- **Minor Comments**  
  - **Concern ID** R1-m1  
  - **Severity** Minor  
  - **Axis** Clarity  
  - **Affected element** Abstract wording  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** The phrase "peptides remain distant, loosely packed random monomers" is internally inconsistent. "Loosely packed" and "distant" describe different spatial arrangements, and "random monomers" is ambiguous.  
  - **Required correction** Clarify the structural state of the peptides, e.g., "remain as dispersed, unstructured monomers with no persistent inter-peptide contacts."

  - **Concern ID** R1-m2  
  - **Severity** Minor  
  - **Axis** Completeness  
  - **Affected element** Simulation details  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** The abstract does not state whether the full-length hIAPP simulations included the disulfide bond between Cys2 and Cys7, which is known to affect the conformational ensemble.  
  - **Required correction** Specify whether the disulfide bond was modeled and, if so, how it was treated in the simulations.

  - **Concern ID** R1-m3  
  - **Severity** Minor  
  - **Axis** Terminology  
  - **Affected element** "Protofibrils"  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** The term "protofibrils" is used without defining the oligomer size or structural model used in the simulations.  
  - **Required correction** Define the protofibril model, including the number of peptide chains and the initial structural template.

- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3. The absence of simulation details, quantitative interaction data, and concentration/control conditions means the central claims of inhibition and disassembly are not currently supported by the provided evidence.

- **Assessment against Nature-style criteria**  
  - **Originality** The concept of ATP as an aggregation inhibitor is not entirely new, but its application to hIAPP and the focus on the adenosine moiety as the key interacting group offers a fresh angle. The originality is moderate and would benefit from comparison with prior computational studies on ATP and amyloid proteins.  
  - **Scientific importance** The potential link between ATP and hIAPP aggregation in T2DM is clinically relevant and could have broad implications for understanding cellular stress responses. However, the importance is diminished by the lack of experimental validation or connection to in vivo conditions.  
  - **Interdisciplinary readership** The topic bridges biophysics, computational chemistry, and diabetes research, which could attract a broad audience. The abstract is written in accessible language, but the lack of quantitative results limits its appeal to specialists.  
  - **Technical soundness** Not assessable from the abstract alone. The absence of methodological detail precludes evaluation of the simulation quality and the validity of the conclusions.  
  - **Readability for nonspecialists** The abstract is generally clear and avoids excessive jargon, but terms such as "N-H-pi stacking" and "protofibrils" may require definition for a general scientific audience.

- **Recommendation posture** Currently not established from the provided evidence. The abstract presents an interesting hypothesis and preliminary computational observations, but the lack of methodological and quantitative detail prevents a rigorous assessment. The authors should be encouraged to provide full simulation details, quantitative interaction analyses, and appropriate controls. If these are supplied and the claims hold, the work could be of interest to the biophysics and amyloid research communities.

## Risk / unsupported claims
- The claim that ATP inhibits hIAPP oligomerization is unsupported without quantitative aggregation metrics (e.g., beta-sheet content, oligomer size distributions) and comparison to control simulations.
- The claim that ATP disassembles preformed protofibrils is unsupported without structural stability metrics (e.g., RMSD, contact maps) over time and across replicates.
- The claim of preferential interaction with specific residues and moieties is unsupported without quantitative contact or energy analyses.
- The claim that the findings can inform amyloid inhibitor design is speculative and not directly supported by the abstract data.
- The biological relevance of the observed effects at millimolar ATP concentrations is not contextualized with respect to physiological or pathological ATP levels.